14-day Premium Trial Subscription Try For FreeTry Free
$0.700
-0.0169 (-2.36%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.600 $0.790 Friday, 3rd May 2024 GLTO stock ended at $0.700. This is 2.36% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.70% from a day low at $0.700 to a day high of $0.740.
90 days $0.561 $0.94
52 weeks $0.500 $3.70

Historical Galecto, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.731 $0.740 $0.700 $0.700 24 044
May 02, 2024 $0.690 $0.732 $0.680 $0.717 277 477
May 01, 2024 $0.675 $0.694 $0.660 $0.680 28 768
Apr 30, 2024 $0.700 $0.700 $0.656 $0.676 144 722
Apr 29, 2024 $0.720 $0.720 $0.670 $0.702 95 945
Apr 26, 2024 $0.677 $0.707 $0.660 $0.705 119 396
Apr 25, 2024 $0.700 $0.700 $0.653 $0.669 26 148
Apr 24, 2024 $0.700 $0.710 $0.650 $0.671 75 047
Apr 23, 2024 $0.675 $0.704 $0.675 $0.701 106 464
Apr 22, 2024 $0.690 $0.720 $0.680 $0.681 61 106
Apr 19, 2024 $0.700 $0.717 $0.681 $0.682 76 556
Apr 18, 2024 $0.655 $0.720 $0.655 $0.720 107 127
Apr 17, 2024 $0.660 $0.686 $0.651 $0.674 59 507
Apr 16, 2024 $0.677 $0.687 $0.640 $0.687 23 604
Apr 15, 2024 $0.680 $0.690 $0.637 $0.687 111 894
Apr 12, 2024 $0.715 $0.725 $0.680 $0.681 234 360
Apr 11, 2024 $0.680 $0.735 $0.660 $0.700 93 096
Apr 10, 2024 $0.710 $0.710 $0.654 $0.680 173 596
Apr 09, 2024 $0.712 $0.720 $0.680 $0.714 62 299
Apr 08, 2024 $0.788 $0.788 $0.600 $0.711 396 756
Apr 05, 2024 $0.728 $0.790 $0.710 $0.760 317 595
Apr 04, 2024 $0.768 $0.775 $0.728 $0.730 78 498
Apr 03, 2024 $0.750 $0.780 $0.728 $0.732 123 384
Apr 02, 2024 $0.780 $0.780 $0.740 $0.765 89 315
Apr 01, 2024 $0.80 $0.80 $0.741 $0.745 163 090
Click to get the best stock tips daily for free!

About Galecto, Inc.

Galecto. Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a ... GLTO Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT